M-1211 - HY-132234
Nur noch %1 verfügbar
Catalog #
HY-132234
Ab
917,00 €
M 1121 is a covalent and orally active inhibitor of the menin-MLL interaction capable of achieving complete and persistent tumor regression[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-132234/M-1211-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| CAS | 2377337-93-2 |
| Storage | -20°C (Powder, sealed storage, away from moisture and light) |
| MWT | 793.00 |
| Solubility | DMSO : 7.69 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | Epigenetic Reader Domain |
| Application: | Cancer-programmed cell death |
|---|